Why the study?
Does nebivolol reduce blood pressure with a more favorable side-effect profile compared to other antihypertensive agents in patients with hypertension?
Does nebivolol reduce blood pressure with a more favorable side-effect profile compared to other antihypertensive agents in patients with hypertension?
Nebivolol is an effective, highly cardioselective third-generation beta-blocker that provides comparable blood pressure reduction to other agents but with a more favorable side-effect profile and unique vasodilatory properties.
Authors
No takes yet. Share an insight, caveat, or question.
May support nebivolol preference for tolerability in hypertension; leaves open need for outcome trials versus alternatives.
Wojciechowski et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: